The Joint Commission takes on the controversial issue of decolonization of patients carrying multidrug-resistant organisms (MDROs) in a new report aimed at health care CEOs. With more hospitals adopting active surveillance cultures to detect MDROs, the question of attempting to decolonize patients has become controversial due to issues of cost and long-term efficacy.